Jump to Navigation
Trends and Sentiments
Comments and Analysis
Mark Zuckerberg will be tackling disease with the $45...
Here’s how much New Yorkers make renting their apartments...
Microsoft’s best hope for a smartphone comeback is due in...
Here's why Japan sends research ships to kill...
Things to know for officer's trial in death of...
Officer says he told boy to show hands before fatal shots
NFL moves Pete Morelli's crew off Sunday night game
Intel’s CEO used a secret budget to jumpstart its new...
Aeromexico says evaluating Delta Airlines offer
Putting a Price on Online Piracy, Ad Fraud
4 Large-Cap Dividend Stocks To Avoid, 1 To Buy: Here's Why
Jim Cramer And Insiders Are Bullish About These Stocks
7 Large-Cap Healthcare Stocks With Strong Corporate Governance
7 Healthcare Stocks Predictive Analysts Expect To Outperform
Billionaires Steve Cohen And Jim Simons Love These Stocks
Insider Buys And Sells: Federal-Mogul, Ulta Salon
The Top 8 Most Profitable Healthcare Stocks
Jim Cramer And Steven Cohen Are Bullish About These Stocks
Insiders Are Bullish On These Healthcare Stocks
Jim Cramer And Ray Dalio Love These Stocks
Stryker Q3 Update
Scavenging For Value Among 52-Week Low Stocks
Donald Yacktman's Recent Top Stock Picks
Curis Earns $8 Million Milestone As NDA Accepted By FDA
5 Surprising Names That Beat The Best Blue Chips
Dividend Contenders: 15 Increases Expected In The Next 10 Weeks
Orthopedic Device Makers' Competitive Advantages Waning
Top Undervalued Q3 Picks Of Top Fund Managers Donald And Stephen Yacktman
25 Companies With Strong Yields, Currently Within 5% Of Their 52 Week Lows
Dividend Contenders: 11 Increases Expected By Groundhog Day
12 Healthcare Stocks With Strong Corporate Governance
11 Highly Liquid Dividend Stocks Undervalued By Target Price
12 Stocks Recently Sold By Jim Cramer's Charitable Trust
2 Medical Device Stocks With Low Valuations
Vancouver CEO tells why he bought controversial...
US Intervention: Before And After
EUR/GBP: 1.4190 USD/EUR: 1.0626 JPY/USD: 122.9155
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions